Insulin-like growth factor I receptor signaling system in JC virus T antigen-induced primitive neuroectodermal tumors--medulloblastomas

J Neurovirol. 2002 Dec:8 Suppl 2:138-47. doi: 10.1080/13550280290101111.

Abstract

Medulloblastomas represent about 25% of all pediatric intracranial neoplasms. These highly malignant tumors arise from the cerebellum, affecting mainly children between ages 5 and 15. Although the etiology of medulloblastomas has not yet been elucidated, several reports suggest that both the cellular protein insulin-like growth factor I (IGF-I) and the early protein of the human polyomavirus JC (JCV T antigen) may contribute to the development of these tumors. The results of this study show a potential functional cooperation between these two proteins in the process of malignant transformation. Both medulloblastoma cell lines and medulloblastoma biopsies are characterized by the abundant presence of the IGF-I receptor (IGF-IR) and its major signaling molecule, insulin receptor substrate 1 (IRS-1). Importantly, IRS-1 is translocated to the nucleus in the presence of the JCV T antigen. Nuclear IRS-1 was detected in T antigen-positive cell lines and in T antigen-positive biopsies from patients diagnosed with medulloblastoma. The IRS-1 domain responsible for a direct JCV T antigen binding was localized within the N-terminal portion of IRS-1 molecule and the competition for IRS-1 T antigen binding by a dominant-negative mutant of IRS-1 inhibited growth and survival of JCV T antigen-transformed cells in anchorage-independent culture condition.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Brain Neoplasms / virology*
  • Cerebellar Neoplasms / virology
  • Humans
  • JC Virus*
  • Medulloblastoma / virology
  • Neuroectodermal Tumors, Primitive / virology*
  • Polyomavirus Infections / complications
  • Polyomavirus Infections / physiopathology*
  • Receptor, IGF Type 1 / physiology*
  • Signal Transduction / physiology
  • Tumor Virus Infections / complications
  • Tumor Virus Infections / physiopathology*

Substances

  • Receptor, IGF Type 1